Insider Transactions by ODINK DEBRA

Symbol Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
ANTH Chief Technology Officer Oct 12, 2015 Sale $6.15 1,205 7,411 7,896 Oct 13, 2015, 08:02 PM
ANTH Chief Technology Officer Mar 25, 2014 Option Exercise $3.30 2,783 9,184 6,601 Mar 27, 2014, 09:57 PM
ANTH Chief Technology Officer Jun 30, 2013 Option Exercise $0.49 2,248 1,102 75,074 Jul 02, 2013, 09:17 PM
ANTH Chief Technology Officer Jan 03, 2013 Option Exercise $0.69 3,409 2,352 31,812 Jan 07, 2013, 09:18 PM
ANTH Chief Technology Officer Jun 30, 2012 Option Exercise $0.69 1,838 1,268 24,821 Jul 03, 2012, 07:27 PM
ANTH Chief Technology Officer Mar 01, 2012 Sale $6.57 2,000 13,140 26,659 Mar 05, 2012, 04:01 PM
ANTH Chief Technology Officer Feb 01, 2012 Sale $7.67 2,000 15,340 21,241 Feb 03, 2012, 04:01 PM
ANTH Chief Technology Officer Jan 10, 2012 Sale $6.51 800 5,205 23,241 Jan 12, 2012, 12:58 PM
ANTH Chief Technology Officer Jan 06, 2012 Sale $6.50 1,200 7,800 24,441 Jan 10, 2012, 02:27 PM
ANTH VP, Pharmaceutical R&D Jun 30, 2011 Option Exercise $8.17 3,670 29,984 25,641 Jul 05, 2011, 06:23 PM
ANTH VP, Pharmaceutical R&D Apr 13, 2011 Option Exercise $1.51 3,311 5,000 29,311 Apr 14, 2011, 08:36 PM
ANTH VP, Pharmaceutical R&D Sep 24, 2010 Buy $4.20 1,000 4,200 26,000 Sep 24, 2010, 09:22 PM

Desktop Version

Symbol Relationship Date Transaction Value($)
ANTH Chief Technology Officer Oct 12, 2015 Sale 7,411
ANTH Chief Technology Officer Mar 25, 2014 Option Exercise 9,184
ANTH Chief Technology Officer Jun 30, 2013 Option Exercise 1,102
ANTH Chief Technology Officer Jan 03, 2013 Option Exercise 2,352
ANTH Chief Technology Officer Jun 30, 2012 Option Exercise 1,268
ANTH Chief Technology Officer Mar 01, 2012 Sale 13,140
ANTH Chief Technology Officer Feb 01, 2012 Sale 15,340
ANTH Chief Technology Officer Jan 10, 2012 Sale 5,205
ANTH Chief Technology Officer Jan 06, 2012 Sale 7,800
ANTH VP, Pharmaceutical R&D Jun 30, 2011 Option Exercise 29,984
ANTH VP, Pharmaceutical R&D Apr 13, 2011 Option Exercise 5,000
ANTH VP, Pharmaceutical R&D Sep 24, 2010 Buy 4,200